Morning Overview on MSN
Scientists found a new trigger for Alzheimer’s and a drug that appears to shut it down
Researchers at ETH Zurich have identified a previously overlooked protein mechanism that drives mitochondrial failure in ...
Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, ...
It clears out toxic proteins in the brain that cause memory loss ...
Medicine may slow decline for some, but dementia care must also protect dignity, identity and story when speech begins to ...
Morning Overview on MSN
A 165,000-patient study found a common dementia drug raised stroke risk in every group
Older adults with dementia who were prescribed risperidone faced a higher risk of stroke regardless of whether they had ...
Alzheimer’s disease slowly strips brain cells of the energy they need to survive. However, one damaged enzyme may be doing more of that work than anyone realized.
The mid-stage disappointment in Alzheimer’s disease delivers another blow to Neuphoria Therapeutics, which in November last year was forced to launch a strategic business review after a Phase 3 trial ...
Researchers at Monash University have identified a promising new approach to tackling Alzheimer's disease. In laboratory studies, they found that a copper-based drug not only reduced the buildup ...
In an exciting breakthrough, researchers have identified cancer drugs that might reverse the effects of Alzheimer's disease in the brain. By analyzing gene expression in brain cells, they discovered ...
Dementia is a condition that results in progressive memory or thinking problems. It's now the most common cause of death in Australia. There are many different causes of dementia, but Alzheimer's ...
New medications and care models are shaping dementia support and reminding us that the disease is not the person.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results